Hypertension and impaired renal function accompany juvenile obesity: The effect of prenatal diet

Kidney International

Volumn 72, Issue 3, 2007, Pages 279-289

  Williams, P J ^a   Kurlak, L O ^a   Perkins, A C ^a   Budge, H ^a   Stephenson, T ^a   Keisler, D ^b   Symonds, M E ^a   Gardner, D S ^c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Fetal kidney development; Glucocorticoids; Maternal nutrition; Obesity

Indexed keywords

ANGIOTENSIN II; CYTOKINE; GLUCOCORTICOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; GLOMERULOSCLEROSIS; HYPERLEPTINEMIA; HYPERTENSION; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; MALNUTRITION; MATERNAL NUTRITION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 34547486885     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002276     Document Type: Article

References (58)

1. Poirier P, Giles TD, Bray GA et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.
2. Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41: 625-633.
3. Agnani S, Vachharajani VT, Gupta R et al. Does treating obesity stabilize chronic kidney disease? BMC Nephrol 2005; 6: 7.
4. Kambham N, Markowitz GS, Valeri AM et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509.
5. Kasiske BL, O'Donnell MP, Cleary MP et al. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 1988; 33: 667-672.
6. Haynes WG. Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypertens Rep 2000; 2: 311-318.
7. Aizawa-Abe M, Ogawa Y, Masuzaki H et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105: 1243-1252.
8. Haynes WG, Morgan DA, Walsh SA et al. Cardiovascular consequences of obesity: role of leptin. Clin Exp Pharmacol Physiol 1998; 25: 65-69.
9. Mark AL, Correia M, Morgan DA et al. State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension 1999; 33: 537-541.
10. Rahmouni K, Haynes WG, Mark AL. Cardiovascular and sympathetic effects of leptin. Curr Hypertens Rep 2002; 4: 119-125.
11. Correia ML, Haynes WG, Rahmouni K et al. The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002; 51: 439-442.
12. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 2001; 14: 103S-115S.
13. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-1788.
14. Mackenzie HS, Brenner BM. Fewer nephrons at birth: a missing link in the etiology of essential hypertension? Am J Kidney Dis 1995; 26: 91-98.
15. Keller G, Zimmer G, Mall G et al. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101-108.
16. Gopalakrishnan GS, Gardner DS, Dandrea J et al. Influence of maternal pre-pregnancy body composition and diet during early-mid pregnancy on cardiovascular function and nephron number in juvenile sheep. Br J Nutr 2005; 94: 938-947.
17. Langley-Evans SC, Welham SJ, Jackson AA. Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci 1999; 64: 965-974.
18. Zandi-Nejad K, Luyckx VA, Brenner BM. Adult hypertension and kidney disease: the role of fetal programming. Hypertension 2006; 47: 502-508.
19. Alexander BT. Fetal programming of hypertension. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1-R10.
20. Whorwood CB, Firth KM, Budge H et al. Maternal undernutrition during early to midgestation programs tissue-specific alterations in the expression of the glucocorticoid receptor, 11β-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin II receptor in neonatal sheep. Endocrinology 2001; 142: 2854-2864.
21. Hoppe CC, Evans RG, Moritz KM et al. Combined prenatal and postnatal protein restriction influences adult kidney structure, function and arterial pressure. Am J Physiol Regul Integr Comp Physiol 2006; 292: R462-R469.
22. McMullen S, Langley-Evans SC. Sex-specific effects of prenatal low-protein and carbenoxolone exposure on renal angiotensin receptor expression in rats. Hypertension 2005; 46: 1374-1380.
23. Wintour EM, Alcorn D, Albiston A et al. The renin-angiotensin system and the development of the kidney and adrenal in sheep. Clin Exp Pharmacol Physiol 1998; 25(Suppl): S97-100.
24. Wintour EM, Moritz KM. Comparative aspects of fetal renal development. Equine Vet J 1997; (Suppl): 51-58.
25. Moritz KM, Dodic M, Wintour EM. Kidney development and the fetal programming of adult disease. Bioessays 2003; 25: 212-220.
26. Gardner DS, Pearce S, Dandrea J et al. Peri-implantation undernutrition programs blunted angiotensin II evoked baroreflex responses in young adult sheep. Hypertension 2004; 43: 1290-1296.
27. Gopalakrishnan GS, Gardner DS, Rhind SM et al. Programming of adult cardiovascular function after early maternal undernutrition in sheep. Am J Physiol Regul Integr Comp Physiol 2004; 287: R12-R20.
28. Bowers MC, Katki KA, Rao A et al. Role of calcitonin gene-related peptide in hypertension-induced renal damage. Hypertension 2005; 46: 51-57.
29. Suzuki H, Tokuriki T, Kamita H et al. Age-related pathophysiological changes in rat oligomeganephronic hypoplastic kidney. Pediatr Nephrol 2006; 21: 637-642.
30. Schwartz MW, Peskind E, Raskind M et al. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996; 2: 589-593.
31. Crook ED. Diabetic renal disease in African Americans. Am J Med Sci 2002; 323: 78-84.
32. Hamoui N, Anthone G, Crookes PF. Calcium metabolism in the morbidly obese. Obes Surg 2004; 14: 9-12.
33. Rutkowski P, Klassen A, Sebekova K et al. Renal disease in obesity: the need for greater attention. J Ren Nutr 2006; 16: 216-223.
34. Vehaskari VM, Aviles DH, Manning J. Prenatal programming of adult hypertension in the rat. Kidney Int 2001; 59: 238-245.
35. Ding G, Reddy K, Kapasi AA et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002; 283: F173-F180.
36. Ruiz-Ortega M, Ruperez M, Esteban V et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 2006; 21: 16-20.
37. Brennan KA, Gopalakrishnan GS, Kurlak L et al. Impact of maternal undernutrition and fetal number on glucocorticoid, growth hormone and insulin-like growth factor receptor mRNA abundance in the ovine fetal kidney. Reproduction 2005; 129: 151-159.
38. Rajah R, Valentinis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997; 272: 12181-12188.
39. Mark AL, Correia ML, Rahmouni K et al. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 2002; 20: 1245-1250.
40. Kassab S, Kato T, Wilkins FC et al. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893-897.
41. Gilbert JS, Lang AL, Grant AR et al. Maternal nutrient restriction in sheep: hypertension, decreased nephron number and altered renal RAS expression in offspring at nine months. J Physiol 2005; 565: 137-147.
42. Mitchell EK, Louey S, Cock ML et al. Nephron endowment and filtration surface area in the kidney after growth restriction of fetal sheep. Pediatr Res 2004; 55: 769-773.
43. Wintour EM, Moritz KM, Johnson K et al. Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment. J Physiol 2003; 549: 929-935.
44. AFRC. Energy and protein requirements of ruminants. An advisory manual prepared by the AFRC technical committee on responses to nutrients. 9th edn. Oxford: CAB International, 1993: 812-815.
45. Gnanalingham MG, Mostyn A, Dandrea J et al. Ontogeny and nutritional programming of uncoupling protein-2 and glucocorticoid receptor mRNA in the ovine lung. J Physiol 2005; 565: 159-169.
46. Hyatt MA, Gopalakrishnan GS, Bispham J et al. Maternal nutrient restriction in early pregnancy programs hepatic mRNA expression of growth-related genes and liver size in adult male sheep. J Endocrinol 2007; 192: 87-97.
47. Dandrea J, Cooper S, Ramsay MM et al. The effects of pregnancy and maternal nutrition on the maternal renin-angiotensin system in sheep. Exp Physiol 2002; 87: 353-359.
48. Twardock AR, Krawiec DR, Itkin RJ. Renal Imaging 1: functional renal scintigraphy. In: Handbook of Veterinary Nuclear Medicine. chap. 15, North Carolina University: Raleigh, 1993, pp 122-130.
49. Fleming JS, Zivanovic MA, Blake GM et al. Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nucl Med Commun 2004; 25: 759-769.
50. Gleadhill A, Marlin D, Harris PA et al. Use of a three-blood-sample plasma clearance technique to measure GFR in horses. Vet J 1999; 158: 204-209.
51. Delavaud C, Bocquier F, Chilliard Y et al. Plasma leptin determination in ruminants: effect of nutritional status and body fatness on plasma leptin concentration assessed by a specific RIA in sheep. J Endocrinol 2000; 165: 519-526.
52. Symonds ME, Phillips ID, Anthony RV et al. Prolactin receptor gene expression and foetal adipose tissue. J Neuroendocrinol 1998; 10: 885-890.
53. Gnanalingham MG, Mostyn A, Gardner DS et al. Developmental regulation of the lung in preparation for life after birth: hormonal and nutritional manipulation of local glucocorticoid action and uncoupling protein-2. J Endocrinol 2006; 188: 375-386.
54. Dodic M, Hantzis V, Duncan J et al. Programming effects of short prenatal exposure to cortisol. FASEB J 2002; 16: 1017-1026.
55. Budhia S, Haring LF, McConnell I et al. Quantitation of ovine cytokine mRNA by real-time RT-PCR. J Immunol Methods 2006; 309: 160-172.
56. Jiang T, Liebman SE, Lucia MS et al. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int 2005; 68: 2608-2620.
57. Xia CF, Bledsoe G, Chao L et al. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats. Am J Physiol Renal Physiol 2005; 289: F622-F631.
58. Lepault E, Celeste C, Dore M et al. Comparative study on microvascular occlusion and apoptosis in body and limb wounds in the horse. Wound Repair Regen 2005; 13: 520-529.